{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:04:16Z","timestamp":1788897856873,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nano.2024.102776","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T22:42:55Z","timestamp":1722724975000},"page":"102776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation"],"prefix":"10.1016","volume":"62","author":[{"given":"Nikitha","family":"Kota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Davila","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixita","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Vander Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Trani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine Ying Xuan","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Grattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2024.102776_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.aar6574","article-title":"Enhancing responses to cancer immunotherapy","volume":"359","author":"Kvistborg","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nano.2024.102776_bb0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.nano.2024.102776_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0020","article-title":"Cancer vaccines in the immunotherapy era: promise and potential","volume":"11","author":"Verma","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"42","key":"10.1016\/j.nano.2024.102776_bb0025","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2023.08.047","article-title":"Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer","volume":"41","author":"Reuschenbach","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2024.102776_bb0030","article-title":"The global impact of hepatitis B vaccination on hepatocellular carcinoma","volume":"10","author":"Flores","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.nano.2024.102776_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146956","article-title":"Vaccines for immunoprevention of cancer","volume":"131","author":"Enokida","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2024.102776_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121297","article-title":"Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines","volume":"280","author":"Viswanath","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2024.102776_bb0045","doi-asserted-by":"crossref","unstructured":"Lei, L. et al. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy. Sci Adv 8, eadc8738.","DOI":"10.1126\/sciadv.adc8738"},{"key":"10.1016\/j.nano.2024.102776_bb0050","article-title":"Bioinspired and biomimetic delivery platforms for cancer vaccines","volume":"34","author":"Liu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2024.102776_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006000","article-title":"Nanovaccine-based strategies to overcome challenges in the whole vaccination cascade for tumor immunotherapy","volume":"17","author":"Qin","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.nano.2024.102776_bb0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41551-022-01000-2","article-title":"Multi-antigen spherical nucleic acid cancer vaccines","volume":"7","author":"Teplensky","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.nano.2024.102776_bb0065","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/acsami.1c18117","article-title":"Anticancer vaccination with immunogenic micelles that capture and release pristine CD8+ T-cell epitopes and adjuvants","volume":"14","author":"Ren","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2024.102776_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2024.102776_bb0075","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/adhm.201500618","article-title":"Injectable, pore-forming hydrogels for in vivo enrichment of immature dendritic cells","volume":"4","author":"Verbeke","year":"2015","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2024.102776_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.954955","article-title":"In situ dendritic cell recruitment and T cell activation for cancer immunotherapy","volume":"13","author":"Han","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2024.102776_bb0085","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8","article-title":"Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells","volume":"28","author":"Sparwasser","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2567.2000.00979.x","article-title":"The effects of DNA containing CpG motif on dendritic cells","volume":"99","author":"Behboudi","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2024.102776_bb0095","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.174.10.6113","article-title":"CpG-independent synergistic induction of \u03b2-chemokines and a dendritic cell phenotype by orthophosphorothioate oligodeoxynucleotides and granulocyte-macrophage colony-stimulating factor in elutriated human primary monocytes1","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0100","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood.V92.10.3730","article-title":"Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Liu","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.nano.2024.102776_bb0105","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1038\/ncomms8556","article-title":"Injectable cryogel-based whole-cell cancer vaccines","volume":"6","author":"Bencherif","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2024.102776_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-P","article-title":"Quantitation of protein","volume":"182","author":"Stoscheck","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nano.2024.102776_bb0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0731-7085(99)00194-6","article-title":"Voltammetric and spectrophotometric techniques for the determination of the antihypertensive drug Prazosin in urine and formulations","volume":"21","author":"Arranz","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nano.2024.102776_bb0120","series-title":"The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals","author":"O\u2019Neil","year":"2001"},{"key":"10.1016\/j.nano.2024.102776_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121374","article-title":"Engineered implantable vaccine platform for continuous antigen-specific immunomodulation","volume":"281","author":"Viswanath","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2024.102776_bb0130","article-title":"Extending drug release from implants via transcutaneous refilling with solid therapeutics","volume":"5","author":"Di Trani","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.nano.2024.102776_bb0135","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1038\/s41467-022-35629-z","article-title":"Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats","volume":"13","author":"Paez-Mayorga","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2024.102776_bb0140","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.2147\/OTT.S197516","article-title":"Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo","volume":"12","author":"Luo","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.nano.2024.102776_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.nano.2024.102776_bb0150","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26889","article-title":"Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden","volume":"2","author":"Scrimieri","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.nano.2024.102776_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.185.3.453","article-title":"Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma","volume":"185","author":"Bloom","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2024.102776_bb0160","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.168.2.951","article-title":"Pre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapy","volume":"168","author":"Khong","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0165","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1084\/jem.184.6.2207","article-title":"Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes","volume":"184","author":"Wang","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2024.102776_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nmat2357","article-title":"Infection-mimicking materials to program dendritic cells in situ","volume":"8","author":"Ali","year":"2009","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2024.102776_bb0175","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1073\/pnas.0914879107","article-title":"Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens","volume":"107","author":"Jordan","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.nano.2024.102776_bb0180","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1007\/s00262-021-02912-9","article-title":"Cancer therapy in mice using a pure population of CD8(+)T cell specific to the AH1 tumor rejection antigen","volume":"70","author":"Stringhini","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2024.102776_bb0185","article-title":"Enhanced antitumor immunity through sequential targeting of PI3K\u03b4 and LAG3","volume":"8","author":"Sarah Nicol","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.nano.2024.102776_bb0190","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1158\/0008-5472.CAN-09-0476","article-title":"Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK\/Rho GTPase activation","volume":"69","author":"Cho","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2024.102776_bb0195","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3892\/mmr.2017.7578","article-title":"Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2","volume":"16","author":"Kim","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.nano.2024.102776_bb0200","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/or.2014.3619","article-title":"Kisspeptin-10 inhibits the migration of breast cancer cells by regulating epithelial-mesenchymal transition","volume":"33","author":"Song","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2024.102776_bb0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0210","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/JLB.3MR0621-616RR","article-title":"Role of IL-6 in dendritic cell functions","volume":"111","author":"Xu","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nano.2024.102776_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nano.2024.102776_bb0225","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/s41467-021-27613-w","article-title":"CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation","volume":"12","author":"Otano","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2024.102776_bb0230","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0235","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/acs.nanolett.3c01775","article-title":"Cancer cell membrane nanodiscs for antitumor vaccination","volume":"23","author":"Guo","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2024.102776_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101651","article-title":"Well-defined mannosylated polymer for peptide vaccine delivery with enhanced antitumor immunity","volume":"11","author":"Lv","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2024.102776_bb0245","article-title":"Hybrid mRNA nano vaccine potentiates antigenic peptide presentation and dendritic cell maturation for effective cancer vaccine therapy and enhances response to immune checkpoint blockade","volume":"12","author":"Shi","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2024.102776_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01184","article-title":"Safety and efficacy of therapeutic cancer vaccines alone or in combination with immune checkpoint inhibitors in cancer treatment","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2024.102776_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16\u2013related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.nano.2024.102776_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172159","article-title":"Cancer vaccine therapeutics: limitations and effectiveness-a literature review","volume":"12","author":"Kaczmarek","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.nano.2024.102776_bb0265","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaci.2024.01.004","article-title":"Engineering platforms for localized long-acting immune modulation","volume":"153","author":"Chua","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nano.2024.102776_bb0270","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/acs.accounts.0c00341","article-title":"Biomaterials as local niches for immunomodulation","volume":"53","author":"Adu-Berchie","year":"2020","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2024.102776_bb0275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425247.2022.2076834","article-title":"Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation","volume":"19","author":"Campa-Carranza","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"9","key":"10.1016\/j.nano.2024.102776_bb0280","doi-asserted-by":"crossref","first-page":"2000027","DOI":"10.1002\/adtp.202000027","article-title":"Emerging technologies for local cancer treatment","volume":"3","author":"Chua","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.nano.2024.102776_bb0285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibtech.2022.11.008","article-title":"Emerging immunomodulatory strategies for cell therapeutics","volume":"41","author":"Chua","year":"2023","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2024.102776_bb0290","article-title":"Sustained intratumoral administration of agonist CD40 antibody overcomes immunosuppressive tumor microenvironment in pancreatic cancer","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2024.102776_bb0295","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijrobp.2020.07.2326","article-title":"Potentiating antitumor efficacy through radiation and sustained intratumoral delivery of anti-CD40 and anti-PDL1","volume":"110","author":"Liu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nano.2024.102776_bb0300","article-title":"Local immunomodulatory strategies to prevent allo-rejection in transplantation of insulin-producing cells","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2024.102776_bb0305","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.molmed.2023.05.008","article-title":"Localized immunomodulation technologies to enable cellular and organoid transplantation","volume":"29","author":"Nash","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nano.2024.102776_bb0310","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963424000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:26:27Z","timestamp":1729754787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963424000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":62,"alternative-id":["S1549963424000455"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2024.102776","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2024.102776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102776"}}